News

An examination of recent failures in Phase III studies and innovative approaches to reduce risk.

Research reveals a need for sponsors to be much more consistent, disciplined and focused in their CRO usage.

Study measures the differing judgment levels between clinical investigators and drug safety experts.

Click the title above to open the Applied Clinical Trials August/September 2016 issue in an interactive PDF format.

Start-up biotech selects Medidata Rave for Phase I and II trials of its investigational compound to address solid tumors and blood cancers.

INC Research announces the launch of its Vaccine Catalyst Site Network.

INC Research has achieved the “Bronze Standard” from the IAOCR’s Clinical Operations Workforce Quality Accreditation program.

ProTrials Research, Inc. and Calithera Biosciences have reached an agreement for early phase clinical trial support.

Bioclinica announces the acquisition of Orlando, Florida based Compass Research.

The drug development process has been seen as inefficient and disappointing by those in the R&D space. Model and Simulation provides a potential relief to these issues by delivering significant business, scientific and clinical value to drug developers.

The European Medicines Agency is proposing changes to the current guidelines on first-on-human clinical trials to improve risk-based strategies.

Medidata announces a collaboration with New York’s Memorial Sloan Kettering Cancer Center on a pilot study to expand the use of mHealth technology in oncology treatment.

The European Medicines Agency (EMA) is proposing changes to the current guidelines on first-in-human clinical trials to improve risk-based strategies. This proposal was made with cooperation from the European Commission and the Member States of the European Union (EU).

Certara announces the addition of Mitsubishi Tanabe to its Simcyp Consortium as the group’s 34th biopharmaceutical company.